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Abstract
Background: The World Health Organization (WHO) recommends same day sputum microscopy (spot-spot) in
preference to conventional strategy (spot-morning) for the diagnosis of smear positive tuberculosis with the view that
completing diagnosis on a single day may be more convenient to the patients and reduce pre-treatment losses to
follow-up.
Methods: We conducted a cross-sectional study in seven selected district level hospitals of Chhattisgarh State,
India. During October 2012 – March 2013, two sputum specimens (spot-early morning) were collected from
consecutively enrolled adult (≥18 years) presumptive TB patients as per current national guidelines. In addition, a
second sample was collected (one hour after the collection of first spot sample) from the same patients. All the
samples were examined by ziehl-Neelsen (ZN) microscopy. McNemar’s test was used to compare statistical
differences in the proportion smear positive between the two approaches (spot-spot versus spot-morning).
Results: Of 2551 presumptive TB patients, 69% were male. All patients provided the first spot specimen, 2361 (93%)
provided the second spot specimen, and 2435 (96%) provided an early morning specimen. 72% of specimens were
mucopurulent in conventional strategy as compared to 60% in same day strategy. The proportion of smear-positive
patients diagnosed by same day microscopy was 14%, as compared to 17% by the conventional method (p<0.001).
A total of 73 (16.9%) potential cases were missed by the same day method compared to only 2 (0.5%) by the
conventional method.
Conclusion: Same-day microscopy method missed 17% of smear-positive cases and contrary to prior perception,
did not increase the proportion of suspects providing the second sample. These findings call for an urgent need to
revisit the WHO recommendation of switching to same-day diagnosis over the current policy.
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Introduction
Despite recent advances in rapid diagnostics, smear
microscopy remains the most widely used test in low-income
high tuberculosis (TB) burden countries [1]. The sputum smear-
positive case detection rates globally and in India have been
stagnant at a level below the 70% target set by the World
Health Organization (WHO) [2]. Hence, efforts to improve the
performance of sputum smear microscopy are a high priority
for global TB control [3]. One reason for poor case detection
could be the suboptimal use of sputum smear microscopy
which currently involves the examination of two specimens
collected over two days. A substantial proportion of patients fail
to complete the two-day evaluation, especially in medical
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college hospitals and district level health facilities, owing to
costs and inconvenience involved in multiple visits. If this
process could be front loaded with both samples collected on
the same day, it may reduce the number of patient drop-outs
during diagnostic evaluation and increase the number of
patients diagnosed and initiated on treatment [4,5]
The WHO recommends that countries that have successfully
implemented the policy for a two-specimen case-finding
strategy should consider switching to same-day diagnosis,
especially in settings where patients are likely to be lost during
the diagnostic process [6]. While sputum smear microscopy
has been criticized for its low sensitivity relative to culture, the
recent WHO recommendation of shifting to a two-smear
strategy and same-day microscopy are likely to reduce
sensitivity even further. Hence, countries have to test this
strategy in their settings before adopting it. Most of the studies
conducted hitherto have been under trial conditions and there
is a lack of evidence from routine programme settings [7–10]
and limited, conflicting information from India. A study from
South India showed that same day microscopy was as effective
as the conventional strategy [11]; whereas another study from
North India showed that same day microscopy missed a
considerable number of smear positive TB patients [12]. Both
the studies were conducted in tertiary care hospitals with a
limited sample size and were not representative of routine
programme conditions. Hence, we aimed to assess if same-
day (spot-spot) microscopy is as effective as the conventional
(spot-morning) strategy in detecting sputum smear positive TB
under programmatic settings in Chhattisgarh state, India. The
specific objectives were to compare between same-day (spot-
spot) microscopy and the conventional (spot-morning) strategy,
(i) the number (proportion) of presumptive TB patients
(erstwhile referred to as ‘TB suspects’) who provided two
sputum specimens, (ii) the quality of specimens, (iii) the
number (proportion) of sputum smear positive TB cases




All participants provided a written informed consent to
participate in the study. Ethics approval was obtained by the
Ethics Advisory Group of the International Union Against
Tuberculosis and Lung Disease (The Union), Paris, France.
Administrative approval to conduct the study was obtained from




In the state of Chhattisgarh in central India (population 25
million), 80% of the population live in rural areas and 30% are
considered ‘tribal’ (as notified by the Government of India).
There are 27 districts in the state with 326 designated
microscopy centers (DMC). At district level, the quality of the
smear microscopy is maintained through external quality
assessment (EQA) by senior tuberculosis laboratory
supervisors (STLS) under the guidance of district tuberculosis
officers (DTO). This is further monitored and evaluated by the
state intermediate reference laboratory (IRL) and the national
reference laboratory (NRL). The EQA consists of on-site
evaluation, un-blinded rechecking and random blinded
rechecking of the selected slides. The study was carried out at
seven district level hospitals (Bastar, Bilaspur, Dantewada,
Dhamtari, Kanker, Mahasamund, Rajnandgaon). These
hospitals have busy outpatient settings with trained laboratory
technicians performing sputum microscopy. Presumptive TB
patients are expected to provide two sputum specimens (spot
and early morning) collected over two consecutive days which
are examined for acid fast bacilli (AFB) by using the Ziehl-
Neelsen staining technique. A patient is diagnosed as smear
positive if either of the specimens is AFB positive as per WHO
guidelines. In Chhattisgarh, of the 118 483 presumptive TB
patients examined in 2012, 13 461 (11%) were smear positive.
Study population and study period
Adult presumptive TB patients (aged ≥18 years) who had
diagnostic smear microscopy in the seven district hospitals
from October 2012 to March 2013 constituted the study
population. The hospitals were selected purposively based on
the area of work of the principal investigator.
Data collection and data validation
The process is shown in Figure 1. Consecutive presumptive
TB patients attending DMCs were provided information on the
study and requested to provide two ‘spot’ sputum samples one
hour apart. The patient was requested to return the next day
with an early morning sample. Specimens were assessed
macroscopically for quality and smears were stained using the
hot Ziehl-Neelsen (ZN) technique. Examination of the second
spot sample was performed in a blinded manner by the LT. The
senior tuberculosis laboratory supervisor (STLS), who was
responsible for the blinding, labeled the second spot specimen
with a different number before examination by the LT. The
original number, new number and results were recorded in a
study register. Smears were considered positive if it had >1
acid fast bacilli per 100 oil immersion fields examined. All
smears were graded according to the WHO/International Union
Against Tuberculosis and Lung Disease scale [13].
Data variables
Information on the following variables – name of the hospital,
age in completed years, sex, laboratory number, quality of
specimen, sputum smear result – were extracted into a pre-
tested structured data collection form by district level
programme staff trained for the purpose. The laboratory
supervisor was trained to review the data collection form for
completeness and consistency which in turn was validated by
the district TB officers (DTO) and medical consultants of the
respective districts.
Same Day Sputum Microscopy
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Data entry and analysis
The data entry operators working for the national TB
programme performed double data entry using EpiData entry
software (Version 3.1, EpiData association, Odense,
Denmark). The two databases were compared and validated
for discrepancies, which were resolved through referral to the
original data source. This finalized database was securely
locked. A duplicate version of the finalized database, after
removing personal identifiers, was used for statistical analysis
using EpiData analysis software (Version 2.2.2.180). For the
purposes of the analysis, sputum quality was graded in the
following manner: (i) mucopurulent if any of two specimens was
mucopurulent, (ii) bloodstained if one of the specimens was
bloodstained and the other was salivary and (iii) salivary when
both specimens were salivary. A patient was considered
‘smear positive’ if any of the two specimens was positive. To
assess grading in case of two positive specimens, the higher
grade was considered. Patients with missing smears were
considered negative and included in analysis. We calculated
incremental yield of the second specimen which referred to
instances where the result of the first specimen was negative
and second specimen was positive expressed as a percentage
of all smear positives diagnosed. Here, the numerator was the
number of patients with the serial results of two specimens
being ‘NP’ (N-negative; P-positive) and the denominator was
the number of all smear positive patients. We used the
matched McNemar test for assessing statistical significance
which was set at 5%.
Results
Of 2551 presumptive TB patients enrolled, 1749 (69%) were
male and the mean (SD) age was 45 (21) years.
Table 1 provides the comparison between the two
approaches. All participants provided the first spot specimen,
2361 (93%) provided the second spot specimen, and 2435
(95%) provided an early morning specimen. 1833 (72%) of the
participants provided mucopurulent specimens in conventional
Figure 1.  Data collection procedure during the study, Chhattisgarh, India, October 2012-March 2013.  
doi: 10.1371/journal.pone.0074964.g001
Same Day Sputum Microscopy
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microscopy as compared to 1540 (60%) in same day
microscopy. The proportion of smear positive patients
diagnosed by same day microscopy was 360 (14%), as
compared to 431 (17%) by the conventional method (p<0.001).
The sputum positivity did not vary by centre.
The incremental yield of the second sputum specimen
(instances when patients were negative on first specimen and
positive only on second) was found to be 15 (4%) in same day
microscopy as compared to 86 (20%) in conventional
microscopy.
Considering the results of all three specimens, there were a
total of 433 smear positive TB cases. Of this, 73 (17%) were
missed by same day microscopy compared to 2 (1%) by the
conventional method (Table 2).
Discussion
This is the first study from India comparing same day
microscopy with the conventional technique in routine program
settings. Same day microscopy missed 17% of smear positive
cases as compared to the conventional technique, thus the
Table 1. Comparison of conventional (spot-early morning)
and same day sputum microscopy (spot-spot) in the







Total 2551 2551  
Number (%) who had both
specimens examined 2435 (96) 2361 (93) <0.001
Quality of Sputum
Specimen*    
Mucopurulent 1833 (72) 1540 (60) <0.001
Blood Stained 29 (1) 30 (1)  
Salivary 685 (27) 975 (38)  
Number (%) smear positive 431 (17) 360 (14) <0.001
Grading of positive smear**    
Scanty Positive 106 (25) 81 (23) <0.001
1+ Positive 116 (27) 109 (30)  
2+ Positive 77 (18) 65 (18)  
3+ Positive 132 (31) 105 (29)  
Incremental yield of second
specimen*** 86 (20) 15 (4) <0.001
*. Quality was graded as mucopurulent if any of the specimens was mucopurulent
and blood stained if one of the specimens was blood stained and other salivary. If
both specimens were salivary, it was considered as salivary. Quality was not
recorded for 6 patients under same day strategy and 4 patients for conventional
strategy.
**. This is among those with at least one positive smear. In case of two positive
specimens, the higher grade was included
***. Incremental yield refers to instances where the result of the first specimen was
negative and second specimen was positive expressed as a percentage of all
smear positives diagnosed
doi: 10.1371/journal.pone.0074964.t001
WHO recommendation of a same day sputum microscopy
strategy may not be applicable in our setting.
The basis of the WHO recommendation comes from a meta-
analysis and several studies which showed same day sputum
microscopy has similar diagnostic accuracy as compared to the
conventional technique [7–10]. While we are not sure of the
reason for the difference in our findings, it might be related to
the differences in patient characteristics and the spectrum of
severity of TB in populations, which could be assessed
indirectly using the distribution of smear quantification among
smear positive TB patients [14]. In settings with a high TB
burden, advanced disease and delayed access to care, most of
the smear positive TB patients are likely to be ‘high positives’
(graded 2+ or 3+), and will be detected in a spot specimen.
While early morning sputum specimens are known to more
sensitive than spot specimens, the advantage is mitigated if
most of the patients have advanced disease and are high
positives [15].
Not all studies that have demonstrated equivalence between
the two approaches have reported on the distribution of smear
quantification [10]. In one study from Ethiopia which showed
equivalence, none of the patients had scanty smears [16]. In
contrast, nearly 50% of all smear positives in our study were
low positives (either scanty or 1+) and hence the advantage of
early morning specimen over second spot specimen is obvious.
This may further indicate good access to services and patients
reaching health facilities at an early stage in the state of
Chhattisgarh. Introduction of the same day sputum microscopy
may not be beneficial in such settings. Second, the higher yield
of the early morning specimen may also be related to better
quality of sputum specimens as compared to spot specimens.
Third, most of the studies showing equivalent performance of
same-day approach were done in well-controlled research
settings with smear and culture examinations performed by
well-trained personnel in reference laboratories [7–10]. In
research settings, technicians are likely to spend more time
reading the smears than in routine laboratories and hence are
more likely to compensate for the difference between spot and
overnight specimens; whereas, we conducted the study in
routine settings and thus reflect operational realities.
The incremental yield of the second specimen was 4% in
same day microscopy compared to 20% in the conventional
method. Therefore, in situations where an early morning
specimen cannot be obtained for any reason, a second spot
will give at least some additional yield in sputum positivity and
should be performed.
Table 2. Comparison of sputum smear microscopy results
in conventional (spot-early morning) and same day sputum
microscopy (spot-spot), Chhattisgarh, India, October 2012-
March 2013 (N=2551).
Strategy Conventional (spot-early morning)
Same Day (spot-spot) Smear Positive Smear Negative
Smear Positive 358 2
Smear Negative 73 2118
doi: 10.1371/journal.pone.0074964.t002
Same Day Sputum Microscopy
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A surprising and counter-intuitive finding of our study was
that the patient drop-out during diagnostic process was
marginally higher with same-day approach as compared to
conventional approach. The reason for this is not known and
may require qualitative studies to assess why patients
preferred to come on the morning of the second day to give
their second sputum specimen instead of waiting for an hour on
the same day. Inconvenience involved in waiting in over-
crowded patient unfriendly health facilities and possible
nosocomial exposure may have deterred the patients from
waiting.
Since 2012, light emitting diode fluorescence microscopy
(LED-FM) has been introduced in about 200 medical college
microscopy centres in India. Given the better sensitivity (10%
more) of LED-FM over ZN microscopy, it may be possible that
LED-FM in spot specimens performs better in detecting acid-
fast bacilli and the difference in performance between spot and
early morning specimen may be lower [17]. Hence, it is
possible that the same day approach could be as effective as
conventional microscopy when LED-FM is used. This is a topic
for future research.
There were a few limitations to our study. First, we
conducted the study in seven purposively selected district
hospitals and hence there may be an issue of generalizability
of the findings. We deliberately chose busy district hospitals
since we expected a higher chance of patient drop-out during
the diagnostic process in these settings. If the same day
approach did not confer any advantage in these settings, it is
unlikely that it would be beneficial in more peripheral health
institutions where most people are likely to provide two
specimens. Second, all participants were provided detailed
information including the need to provide second spot and early
morning specimens during the process of informed consent.
This might have influenced them to adhere to the diagnostic
process and may not reflect the drop-outs that would have
happened in routine conditions. Third, given the design of the
study, we could not assess the effect of the different
approaches on treatment uptake. Fourth, we did not have any
information on HIV status of the participants or the proportion
of TB patients with cavitary lesions and if that impacted the
results. However, we feel that this might not have impacted
greatly as the study was conducted in a low HIV prevalence
setting (with an estimated HIV prevalence of 0.22% among
adults aged 15-49 years in the year 2011) [18] and most of
smear positive TB patients had their smears graded ‘low
positive’ providing an indirect indication of likelihood of cavitary
lesions.
Conclusion
Same day microscopy missed 17% of smear-positive cases
when compared to the conventional strategy. In contrast to
prior studies, this strategy did not increase the proportion of
suspects providing the second sample. The study findings call
for a need to revisit the WHO recommendation of switching to
same-day diagnosis. Countries should be cautious in their
approach, pilot test the same day microscopy strategy and
ascertain its usefulness before making decisions on a wider
scale-up.
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